# Edible Garden AG Inc: financial statements, quarterly

EDBL · Nasdaq · CIK 1809750 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/edbl.md) · [Financials](/companies/edbl/financials.md) · [Filings](/companies/edbl/filings.md) · [Insiders](/companies/edbl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/edbl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,289](/filings/0001477932-24-007062.md) | [4,084 d](/filings/0001477932-25-002281.md) | [3,132](/filings/0001477932-25-003815.md) | [4,268](/filings/0001477932-25-005936.md) | [2,584](/filings/0001477932-25-008250.md) | [3,872 d](/filings/0001477932-26-001867.md) | [2,718](/filings/0001477932-26-003238.md) | [3,146](/filings/0001477932-26-005081.md) | [2,817](/filings/0001477932-25-008250.md) | [4,129 d](/filings/0001477932-26-001867.md) | [3,341](/filings/0001477932-26-003238.md) | [3,550](/filings/0001477932-26-005081.md) |
| Cost of revenue | $k | [3,277](/filings/0001477932-24-007062.md) | [3,802 d](/filings/0001477932-25-002281.md) | [3,109](/filings/0001477932-25-003815.md) | [2,702](/filings/0001477932-25-005936.md) | [1,885](/filings/0001477932-25-008250.md) | [3,849 d](/filings/0001477932-26-001867.md) | [2,630](/filings/0001477932-25-003815.md) | [2,512](/filings/0001477932-25-005936.md) | [2,544](/filings/0001477932-25-008250.md) | [5,328 d](/filings/0001477932-26-001867.md) | not reported | not reported |
| Gross profit | $k | [12.0](/filings/0001477932-24-007062.md) | [282 d](/filings/0001477932-25-002281.md) | [23.0](/filings/0001477932-25-003815.md) | [1,566](/filings/0001477932-25-005936.md) | [699](/filings/0001477932-25-008250.md) | [23.0 d](/filings/0001477932-26-001867.md) | [88.0](/filings/0001477932-25-003815.md) | [634](/filings/0001477932-25-005936.md) | [273](/filings/0001477932-25-008250.md) | [(1,199) d](/filings/0001477932-26-001867.md) | not reported | not reported |
| Selling, general and administrative | $k | [2,387](/filings/0001477932-24-007062.md) | [2,551 d](/filings/0001477932-25-002281.md) | [3,884](/filings/0001477932-25-003815.md) | [2,748](/filings/0001477932-25-005936.md) | [2,189](/filings/0001477932-25-008250.md) | [2,764 d](/filings/0001477932-26-001867.md) | [2,608](/filings/0001477932-26-003238.md) | [3,993](/filings/0001477932-26-005081.md) | [3,831](/filings/0001477932-25-008250.md) | [4,524 d](/filings/0001477932-26-001867.md) | [2,905](/filings/0001477932-26-003238.md) | [3,134](/filings/0001477932-26-005081.md) |
| Operating income | $k | [(2,375)](/filings/0001477932-24-007062.md) | [(2,955) d](/filings/0001477932-25-002281.md) | [(3,861)](/filings/0001477932-25-003815.md) | [(1,182)](/filings/0001477932-25-005936.md) | [(1,490)](/filings/0001477932-25-008250.md) | [(2,741) d](/filings/0001477932-26-001867.md) | [(2,926)](/filings/0001477932-26-003238.md) | [(3,593)](/filings/0001477932-26-005081.md) | [(3,558)](/filings/0001477932-25-008250.md) | [(5,723) d](/filings/0001477932-26-001867.md) | [(6,678)](/filings/0001477932-26-003238.md) | [(3,177)](/filings/0001477932-26-005081.md) |
| Interest expense | $k | [57.0](/filings/0001477932-24-007062.md) | [56.0 d](/filings/0001477932-25-002281.md) | [117](/filings/0001477932-25-003815.md) | [419](/filings/0001477932-25-005936.md) | [409](/filings/0001477932-25-008250.md) | [275 d](/filings/0001477932-26-001867.md) | [440](/filings/0001477932-26-003238.md) | [389](/filings/0001477932-26-005081.md) | [387](/filings/0001477932-25-008250.md) | [207 d](/filings/0001477932-26-001867.md) | [150](/filings/0001477932-26-003238.md) | [163](/filings/0001477932-26-005081.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001477932-26-003238.md) | [0.0](/filings/0001477932-26-005081.md) | not reported | not reported | [(3,354)](/filings/0001477932-26-003238.md) | [0.0](/filings/0001477932-26-005081.md) |
| Net income | $k | [(2,431)](/filings/0001477932-24-007062.md) | [(4,240) d](/filings/0001477932-25-002281.md) | [(3,977)](/filings/0001477932-25-003815.md) | [(1,932)](/filings/0001477932-24-004821.md) | [(2,063)](/filings/0001477932-25-008250.md) | [(3,079) d](/filings/0001477932-26-001867.md) | [(3,324)](/filings/0001477932-26-003238.md) | [(4,043)](/filings/0001477932-26-005081.md) | [(4,045)](/filings/0001477932-25-008250.md) | [3,913 d](/filings/0001477932-26-001867.md) | [(3,669)](/filings/0001477932-26-003238.md) | [(3,259)](/filings/0001477932-26-005081.md) |
| Diluted EPS | $ per share | not reported | not reported | [(341.14)](/filings/0001477932-25-003815.md) | [(30.02)](/filings/0001477932-25-005936.md) | [16.32](/filings/0001477932-25-008250.md) | not reported | [(24.74)](/filings/0001477932-26-003238.md) | [(2960.37)](/filings/0001477932-26-005081.md) | [1.38](/filings/0001477932-25-008250.md) | not reported | [(5.25)](/filings/0001477932-26-003238.md) | [(18.79)](/filings/0001477932-26-005081.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.1](/filings/0001477932-26-005081.md) | not reported | [0.7](/filings/0001477932-26-005081.md) |
| Current assets | $m | [5.2](/filings/0001477932-23-008264.md) | [2.6](/filings/0001477932-25-002281.md) | [2.6](/filings/0001477932-24-002897.md) | [6.3](/filings/0001477932-24-004821.md) | [5.4](/filings/0001477932-24-007062.md) | [7.4](/filings/0001477932-26-001867.md) | [4.2](/filings/0001477932-25-003815.md) | [5.9](/filings/0001477932-25-005936.md) | [4.9](/filings/0001477932-25-008250.md) | [5.8](/filings/0001477932-26-005081.md) | [5.6](/filings/0001477932-26-003238.md) | [6.8](/filings/0001477932-26-005081.md) |
| Total assets | $m | [10.1](/filings/0001477932-23-008264.md) | [6.7](/filings/0001477932-25-002281.md) | [6.3](/filings/0001477932-24-002897.md) | [9.9](/filings/0001477932-24-004821.md) | [8.9](/filings/0001477932-24-007062.md) | [11.9](/filings/0001477932-26-001867.md) | [8.5](/filings/0001477932-25-003815.md) | [21.8](/filings/0001477932-25-005936.md) | [20.1](/filings/0001477932-25-008250.md) | [20.6](/filings/0001477932-26-005081.md) | [17.5](/filings/0001477932-26-003238.md) | [27.7](/filings/0001477932-26-005081.md) |
| Current liabilities | $m | [2.0](/filings/0001477932-23-008264.md) | [2.9](/filings/0001477932-25-002281.md) | [9.6](/filings/0001477932-24-002897.md) | [8.6](/filings/0001477932-24-004821.md) | [4.9](/filings/0001477932-24-007062.md) | [6.2](/filings/0001477932-26-001867.md) | [5.2](/filings/0001477932-25-003815.md) | [4.0](/filings/0001477932-25-005936.md) | [6.1](/filings/0001477932-25-008250.md) | [7.1](/filings/0001477932-26-005081.md) | [7.7](/filings/0001477932-26-003238.md) | [9.3](/filings/0001477932-26-005081.md) |
| Total liabilities | $m | [6.1](/filings/0001477932-23-008264.md) | [6.9](/filings/0001477932-25-002281.md) | [10.4](/filings/0001477932-24-002897.md) | [9.4](/filings/0001477932-24-004821.md) | [5.6](/filings/0001477932-24-007062.md) | [7.8](/filings/0001477932-26-001867.md) | [6.6](/filings/0001477932-25-003815.md) | [5.2](/filings/0001477932-25-005936.md) | [7.2](/filings/0001477932-25-008250.md) | [8.1](/filings/0001477932-26-005081.md) | [8.6](/filings/0001477932-26-003238.md) | [22.1](/filings/0001477932-26-005081.md) |
| Long-term debt | $m | [4.1](/filings/0001477932-23-008264.md) | [4.0](/filings/0001477932-25-002281.md) | [0.9](/filings/0001477932-24-002897.md) | [0.8](/filings/0001477932-24-004821.md) | [0.6](/filings/0001477932-24-007062.md) | [0.5](/filings/0001477932-26-001867.md) | [0.4](/filings/0001477932-25-003815.md) | [0.3](/filings/0001477932-25-005936.md) | [0.2](/filings/0001477932-25-008250.md) | [0.2](/filings/0001477932-26-005081.md) | [0.2](/filings/0001477932-26-003238.md) | [12.2](/filings/0001477932-26-005081.md) |
| Short-term borrowings | $m | [0.4](/filings/0001477932-23-008264.md) | [0.4](/filings/0001477932-25-002281.md) | [4.4](/filings/0001477932-24-002897.md) | [5.0](/filings/0001477932-24-004821.md) | [1.4](/filings/0001477932-24-007062.md) | [1.9](/filings/0001477932-26-001867.md) | [1.6](/filings/0001477932-25-003815.md) | [1.3](/filings/0001477932-25-005936.md) | [2.1](/filings/0001477932-25-008250.md) | [1.4](/filings/0001477932-26-005081.md) | [2.2](/filings/0001477932-26-003238.md) | [1.6](/filings/0001477932-26-005081.md) |
| Shareholders' equity | $m | [4.0](/filings/0001477932-24-007062.md) | [(0.3)](/filings/0001477932-26-001867.md) | [(4.1)](/filings/0001477932-25-005936.md) | [0.5](/filings/0001477932-25-008250.md) | [3.3](/filings/0001477932-25-008250.md) | [4.1](/filings/0001477932-26-005081.md) | [1.9](/filings/0001477932-26-005081.md) | [1.6](/filings/0001477932-26-005081.md) | [12.9](/filings/0001477932-25-008250.md) | [12.5](/filings/0001477932-26-005081.md) | [8.8](/filings/0001477932-26-005081.md) | [5.6](/filings/0001477932-26-005081.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,210) d](/filings/0001477932-24-007062.md) | [(1,753) d](/filings/0001477932-25-002281.md) | [(1,059)](/filings/0001477932-25-003815.md) | [(4,590) d](/filings/0001477932-25-005936.md) | [(1,112) d](/filings/0001477932-25-008250.md) | [(1,755) d](/filings/0001477932-26-001867.md) | [(3,332)](/filings/0001477932-26-003238.md) | [(3,432) d](/filings/0001477932-26-005081.md) | [(2,378) d](/filings/0001477932-25-008250.md) | [(2,662) d](/filings/0001477932-26-001867.md) | [251](/filings/0001477932-26-003238.md) | [644 d](/filings/0001477932-26-005081.md) |
| Capital expenditure | $k | [209 d](/filings/0001477932-24-007062.md) | [222 d](/filings/0001477932-25-002281.md) | [55.0](/filings/0001477932-25-003815.md) | [112 d](/filings/0001477932-25-005936.md) | [10.0 d](/filings/0001477932-25-008250.md) | [126 d](/filings/0001477932-26-001867.md) | [79.0](/filings/0001477932-26-003238.md) | [54.0 d](/filings/0001477932-26-005081.md) | [409 d](/filings/0001477932-25-008250.md) | [96.0 d](/filings/0001477932-26-001867.md) | [104](/filings/0001477932-26-003238.md) | [3,260 d](/filings/0001477932-26-005081.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [11.7](/filings/0001477932-25-003815.md) | [64.4](/filings/0001477932-25-005936.md) | [126](/filings/0001477932-25-008250.md) | [134](/filings/0001477932-26-003238.md) | [4.7](/filings/0001477932-26-005081.md) | [2,934](/filings/0001477932-25-008250.md) | [752](/filings/0001477932-26-003238.md) | [180](/filings/0001477932-26-005081.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,951,509 at 2026-08-06, from the cover of the [10-Q filed 2026-08-14](/filings/0001477932-26-005081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.